Immix Biopharma
IMMX
9.49
-0.15
-1.56%
Immix Biopharma
US · IMMX
#3426 by market cap
Listed 2021
9.49
-0.15
-1.56%
Live - 5344 symbols - heartbeat 470s ago
· 2026-10-08 09:01
Pre-market
9.42
-0.78%
After-hours
9.49
0.00%
- Market cap
- 788.42M
- P/E (TTM)i
- -10.78
- P/Bi
- 3.44
- EPSi
- -0.89
- Div yieldi
- 0.00%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on IMMX?
Anonymous reader poll. Unscientific, not investment advice.
About Immix Biopharma
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
- Founded
- 2012
- CEO
- Dr. Ilya Rachman, M.B.A.,M.D.,PhD
- Employees
- 21
- Headquarters
- Los Angeles, California, United States of America
- Fiscal year end
- 12-31
- Website
- immixbio.com
Company profile
- Exchange
- US
- Symbol
- IMMX
- Market-cap rank
- #3426
- Listing date
- 2021-12-16
- Market cap
- 788.42M
- Float cap
- 642.53M
- Shares out
- 83.08M
- Float shares
- 67.71M
Sectors & themes
Quote time 2026-10-08 09:01:25 · For reference only, not investment advice and not tailored to your situation.